Welcome to our dedicated page for Datametrex Ai Li news (Ticker: DTMXF), a resource for investors and traders seeking the latest updates and insights on Datametrex Ai Li stock.
Datametrex AI Limited reports developments across technology solutions, artificial intelligence and healthcare, with recurring updates tied to data centre operations, private cloud infrastructure and managed services for enterprise customers. Company announcements describe purchase orders for hyperconverged infrastructure software, technical support and AI-enabled resource optimization, including work delivered through Datametrex Korea.
News also covers the company's use of AI-assisted functionality in electronic medical records and the intellectual property activities of wholly owned subsidiary Paymetrex Payment Solutions Inc. Paymetrex updates include patent licensing and monetization initiatives involving secure transaction processing, payment authorization workflows, mobile-based acceptance architectures and potential relevance to SoftPOS and next-generation secure payment environments.
Datametrex (OTC:DTMXF) announced multiple enterprise infrastructure contracts totaling about CAD $1.8 million for Nutanix-based data centre modernization. The company expects roughly 10% net profit from these projects, which focus on upgrading server infrastructure and delivering Nutanix hyperconverged infrastructure to enhance performance, scalability, and operational efficiency.
Datametrex AI (OTC:DTMXF) announced that Hilco Global has completed its initial qualifying due diligence review of the patent portfolio owned by subsidiary Paymetrex Payment Solutions. The portfolio passed Hilco’s internal qualification process and is slated to advance into a structured licensing initiative focused on SoftPOS and mobile payment technologies.
The parties anticipate a broader licensing program could begin in about two months, though Datametrex cautions the initiative is exploratory and there is no assurance of any licensing, royalty, or other commercial agreements.
Datametrex AI (OTC:DTMXF) announced that subsidiary Imagine Health has gained teaching facility status at its Calgary Capitol Hill clinic through a partnership with a University of Calgary faculty member, Dr. Michael Tam.
The move supports physician recruitment, rheumatology access via Dr. Richard Akintayo, and added walk-in and family care in Edmonton from June 1, 2026.
Datametrex (OTC:DTMXF) announced that subsidiary Paymetrex is expanding its patent monetization strategy to evaluate licensing opportunities in quantum-resilient and next-generation encryption technologies.
Paymetrex says its portfolio may be relevant, but no IP has been validated, licensed, or commercialized for post-quantum uses; the review is exploratory and not material at this time.
Datametrex (OTC:DTMXF) received purchase orders totaling $6,000,000 from an international Fortune 500 conglomerate for data centre expansion and optimization announced April 9, 2026. The orders comprise $5,000,000 software licensing and $1,000,000 technical support/maintenance.
Contracts run over a five-year term with $2,000,000 payable upfront and $1,000,000 payable each January thereafter, and an estimated profit margin of approximately 25%.
Datametrex (OTC:DTMXF) announced that subsidiary Paymetrex signed an agreement on March 23, 2026 with Hilco Global's IP Services to support monetization of Paymetrex's patent portfolio. The engagement targets SoftPOS and mobile payment acceptance opportunities and will use IP valuation, licensing and AI-based analytics.
The collaboration aims to evaluate licensing, structured sales, auctions and other pathways to unlock patent value.
Datametrex AI (OTC:DTMXF) said its subsidiary Paymetrex and AnywhereCommerce entered a royalty-bearing license on March 17, 2026, covering portions of Paymetrex's U.S. and Canadian patents related to secure transaction processing and mobile acceptance architectures.
The release links the license to the rapidly expanding SoftPOS market, cites Juniper Research projecting SoftPOS transaction value of $540 billion by 2030 (from $22.9 billion in 2025), and notes AnywhereCommerce will deploy the licensed technology while Paymetrex will use AI analytics to prioritize licensing opportunities.
Datametrex (OTC:DTMXF) announced on March 10, 2026 the integration of AI capabilities into its EMR platform to assist physicians at the point of care. Key features include automated clinical documentation, intelligent document classification, real-time charting suggestions, and AI-generated post-visit care plans. The company emphasized clinician control over final clinical and prescribing decisions and compliance with patient-data regulations. Datametrex positions the upgrade as a workflow-efficiency measure to reduce administrative burden and support follow-up care and chronic condition management.
Datametrex (OTC:DTMXF) said its subsidiary Paymetrex engaged Pelent Patent Analytics effective February 13, 2026 to accelerate a patent licensing and monetization program.
Pelent's AI, trained on confidential licensing campaigns, will support target identification, prioritize enforcement/licensing, and provide Evidence of Use services under a four-month initial term.
Datametrex (OTC:DTMXF) received a Purchase Order of approximately $1,000,000 from a Fortune 500 conglomerate headquartered in South Korea on February 18, 2026. The order is for Nutanix-based hyperconverged infrastructure software licenses and carries an estimated profit margin of ~53%.
This P.O. validates Datametrex's data centre operations and supports its land-and-expand strategy, managed services platform, and efforts to build a predictable, recurring revenue base via Datametrex Korea.